🇺🇸 Enbrel in United States

404,486 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 72,414 reports (17.9%)
  2. Injection Site Pain — 56,422 reports (13.95%)
  3. Rheumatoid Arthritis — 44,830 reports (11.08%)
  4. Arthralgia — 43,888 reports (10.85%)
  5. Pain — 42,141 reports (10.42%)
  6. Injection Site Erythema — 40,943 reports (10.12%)
  7. Fatigue — 29,425 reports (7.27%)
  8. Pain In Extremity — 25,053 reports (6.19%)
  9. Joint Swelling — 24,870 reports (6.15%)
  10. Psoriasis — 24,500 reports (6.06%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Enbrel approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Enbrel in United States?

LG Life Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.